Steroid-Refractory Chronic Graft-versus-Host Disease Treated with Ruxolitinib: A Narrative Review of Symptom Burden and Return to Daily Life. (2023). Journal of Clinical Case Studies and Reviews, 4(1), 31-36. https://doi.org/10.5281/zenodo.22227762